Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease; Jiménez Navarro M, Avanzas P, Valencia F, Ballesteros S, Ruiz-Nodar JM, Ferreiro JL, Tello Montoliu A, Marín F; Expert Reviewers for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease; Pérez de Prado A, Romero Moreno M, Bravo MS, Ruiz Ortiz M, Escobar C, Roldán I, Vivas Balcones D; SEC Guidelines Committee; San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R. SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease, et al. Among authors: tello montoliu a. Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):6-12. doi: 10.1016/j.rec.2017.11.019. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29277237 English, Spanish. No abstract available.
[Can we expect polymorphisms to answer our questions?].
Marín F, Roldán V, Tello-Montoliu A. Marín F, et al. Among authors: tello montoliu a. Rev Esp Cardiol. 2004 Nov;57(11):1129. Rev Esp Cardiol. 2004. PMID: 15544764 Free article. Spanish. No abstract available.
Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome.
Tello-Montoliu A, Jover E, Marín F, Bernal A, Lozano ML, Sánchez-Vega B, Pastor FJ, Hurtado JA, Valdés M, Vicente V, Rivera J. Tello-Montoliu A, et al. Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):219-26. doi: 10.1016/j.recesp.2011.07.013. Epub 2011 Nov 23. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22116003 English, Spanish.
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
Capranzano P, Ferreiro JL, Ueno M, Capodanno D, Dharmashankar K, Darlington A, Desai B, Tello-Montoliu A, Rollini F, Angiolillo DJ. Capranzano P, et al. Among authors: tello montoliu a. Catheter Cardiovasc Interv. 2013 Jan 1;81(1):42-9. doi: 10.1002/ccd.24416. Epub 2012 Apr 17. Catheter Cardiovasc Interv. 2013. PMID: 22431415 Clinical Trial.
Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation.
Arribas F; SEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:; Arribas F, Roldán I, Luis Merino J, Roldán V, Arenal Ÿ, Tamargo J, Ruiz-Granell R, Mont L, Anguita M, Marín F; Reviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:; Barrios Alonso V, Barón G, Esquivias, Cosín Sales J, Díaz Infante E, Escobar Cervantes C, Ferreiro Gutiérrez JL, Guerra Ramos JM, Jiménez Candil FJ, Pérez Castellano N, Sambola Ayala A, Tello Montoliu A; SEC Guidelines Committee:; San Román A, Alfonso F, Arribas F, Evangelista A, Ferreira I, Jiménez M, Marín F, de Isla LP, Rodríguez Padial L, Sánchez PL, Sionis A, Vázquez R. Arribas F, et al. Among authors: tello montoliu a. Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):2-8. doi: 10.1016/j.rec.2016.11.032. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28038728 English, Spanish. No abstract available.
Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes.
Esteve-Pastor MA, Ruíz-Nodar JM, Orenes-Piñero E, Rivera-Caravaca JM, Quintana-Giner M, Véliz-Martínez A, Tello-Montoliu A, PerniasEscrig V, Sandín Rollán M, Vicente-Ibarra N, MacíasVillanego MJ, Candela Sánchez E, Carrillo Alemán L, Lozano T, Valdés M, Marín F. Esteve-Pastor MA, et al. Among authors: tello montoliu a. J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):57-65. doi: 10.1177/1074248417724869. Epub 2017 Aug 9. J Cardiovasc Pharmacol Ther. 2018. PMID: 28789568
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.
Vivas D, Roldán I, Ferrandis R, Marín F, Roldán V, Tello-Montoliu A, Ruiz-Nodar JM, Gómez-Doblas JJ, Martín A, Llau JV, Ramos-Gallo MJ, Muñoz R, Arcelus JI, Leyva F, Alberca F, Oliva R, Gómez AM, Montero C, Arikan F, Ley L, Santos-Bueso E, Figuero E, Bujaldón A, Urbano J, Otero R, Hermida JF, Egocheaga I, Llisterri JL, Lobos JM, Serrano A, Madridano O, Ferreiro JL; Expert reviewers. Vivas D, et al. Among authors: tello montoliu a. Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):553-564. doi: 10.1016/j.rec.2018.01.029. Epub 2018 Jun 8. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29887180 English, Spanish.
High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention.
Ferreiro JL, Vivas D, De La Hera JM, Marcano AL, Lugo LM, Gómez-Polo JC, Silva I, Tello-Montoliu A, Marín F, Roldán I. Ferreiro JL, et al. Among authors: tello montoliu a. Thromb Res. 2019 Mar;175:95-101. doi: 10.1016/j.thromres.2019.01.021. Epub 2019 Jan 31. Thromb Res. 2019. PMID: 30738371
102 results